[1] Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol, 2019,70:151-171.
[2] Younossi ZM, Blissett D, Blissett R, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology,2016,64:1577-1586.
[3] Dillon JF, Miller MMH, Robinson EM, et al. Intelligent liver function testing (iLFT): a trial of automated diagnosis and staging of liver disease in primary care. J Hepatol,2019,71:699-706.
[4] Parkes J, Roderick P, Harris S, et al. Enhanced liver fifibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut,2010,59:1245-1251. |
